“katrine-bosley” Archives

in
Entry Author Date Location
Gene Editing Execs Talk Scientific, Regulatory Hurdles At BIO Panel 02/10/16 Boston
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO 01/25/16 Boston
Eight Things You Might Not Have Known Until Editas Filed Its S-1 01/04/16 Boston
Historic CRISPR Patent Fight Primed To Become Head-To-Head Battle 01/04/16 San Francisco
Pharmabros, Designer Babies, And Other Final Words For 2015 12/24/15 National
Veterans Day Special Ending For Our Nov. 17 Health Summit: Save $75 11/09/15 Boston
Special Rate Ends Today For Our Nov. 17 Health Summit: Save $100 11/03/15 Boston
McGuire, Bosley, Watson, & More at Our Health Summit—Register Today 10/26/15 Boston
Agenda Live for Our Healthcare Summit Nov. 17 at the Broad Institute 10/15/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
Juno, Editas To Collaborate On CRISPR-Juiced Cancer Immunotherapy 05/27/15 Seattle
New Cubist CEO Joins Our Healthcare Summit Nov. 18—Get Your Invite 10/31/14 Boston
The Second Xconomy Boston Healthcare Summit: Request An Invitation 10/02/14 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
At Two-Year Mark, JOBS Act Is Regulation Even A Biotech Can Love 05/01/14 San Francisco
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche” 01/02/14 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Red (and Green) Flags To Look for With Biotech’s Buyside Investors 10/31/13 Boston
Starting a Company Is Hard. Good Health Insurance Makes It Easier. 08/30/13 Boston
Who Should Biotech Pros Follow on Twitter? An Update for 2013 08/19/13 National
Page 1 of 2 next page »